|
Sign In to gain access to subscriptions and/or personal tools.
|
Oligoclonal bands in Devics neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations
R Bergamaschi
Centre for Multiple Sclerosis, Neurological Institute IRCCS C. Mondino, University of Pavia, Pavia, Italy, roberto.bergamaschi{at}mondino.it
S Tonietti
Centre for Multiple Sclerosis, Neurological Institute IRCCS C. Mondino, University of Pavia, Pavia, Italy
D Franciotta
Laboratory of Neuroimmunology, Neurological Institute IRCCS C. Mondino, University of Pavia, Pavia, Italy
E Candeloro
Centre for Multiple Sclerosis, Neurological Institute IRCCS C. Mondino, University of Pavia, Pavia, Italy
E Tavazzi
Centre for Multiple Sclerosis, Neurological Institute IRCCS C. Mondino, University of Pavia, Pavia, Italy
G Piccolo
Centre for Multiple Sclerosis, Neurological Institute IRCCS C. Mondino, University of Pavia, Pavia, Italy
A Romani
Centre for Multiple Sclerosis, Neurological Institute IRCCS C. Mondino, University of Pavia, Pavia, Italy
V Cosi
Centre for Multiple Sclerosis, Neurological Institute IRCCS C. Mondino, University of Pavia, Pavia, Italy
We studied repeated cerebrospinal fluids of patients with Devics neuromyelitis optica (NMO) and multiple sclerosis (MS). Variations of oligoclonal bands (OBs) had opposite trends in the two groups. In MS, O Bs were detected in 399 of 411 patients (97%) and never disappeared. In NMO, O Bs were detected in three of 11 patients (27%) and always disappeared. The hypothesis that NMO and MS follow distinct patho genetic pathways is supported by our findings, which can be useful for the differentiatio n of NMO from MS.
Key Words: cerebrospinal fluid Devics syndrome multiple sclerosis neuromyelitis optica oligoclonal bands
Multiple Sclerosis, Vol. 10, No. 1,
2-4 (2004)
DOI: 10.1191/1352458504ms988oa

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Miller, B. Weinshenker, M Filippi, B. Banwell, J. Cohen, M. Freedman, S. Galetta, M Hutchinson, R. Johnson, L Kappos, et al.
Differential diagnosis of suspected multiple sclerosis: a consensus approach
Multiple Sclerosis,
November 1, 2008;
14(9):
1157 - 1174.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J-S Wu, M-N Zhang, W M Carroll, and A G Kermode
Characterisation of the spectrum of demyelinating disease in Western Australia
J. Neurol. Neurosurg. Psychiatry,
September 1, 2008;
79(9):
1022 - 1026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Okamoto, M. Ogawa, Youwei Lin, M. Murata, S. Miyake, and T. Yamamura
Review: Treatment of neuromyelitis optica: Current debate
Therapeutic Advances in Neurological Disorders,
July 1, 2008;
1(1):
43 - 52.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Franciotta, S. Jarius, and F. Aloisi
More on Multiple Sclerosis and Neuromyelitis Optica
Arch Neurol,
December 1, 2007;
64(12):
1802 - 1802.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Weinshenker, S. Galetta, J. Bennett, D. Kerr, and E. M. Frohman
More on Multiple Sclerosis and Neuromyelitis Optica Reply
Arch Neurol,
December 1, 2007;
64(12):
1802 - 1803.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. de Seze, M. Debouverie, H. Zephir, C. Lebrun, F. Blanc, V. Bourg, S. Wiertlewski, S. Pittion, D. Laplaud, E. Le Page, et al.
Acute Fulminant Demyelinating Disease: A Descriptive Study of 60 Patients
Arch Neurol,
October 1, 2007;
64(10):
1426 - 1432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Nakamura, I. Nakashima, S. Sato, I. Miyazawa, K. Fujihara, and Y. Itoyama
Clinical and laboratory features of neuromyelitis optica with oligoclonal IgG bands
Multiple Sclerosis,
April 1, 2007;
13(3):
332 - 335.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Kister, S. Gulati, C. Boz, R. Bergamaschi, G. Piccolo, J. Oger, and M. L. Swerdlow
Neuromyelitis optica in patients with myasthenia gravis who underwent thymectomy.
Arch Neurol,
June 1, 2006;
63(6):
851 - 856.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|